Insider trading investigation extended to pharmaceutical stocks


A US investigation into insider trading on Wall Street has been extended to shares in the biotech and pharmaceutical sectors, the Financial Times reports, citing a source familiar with the matter. The FBI and the attorney generalâ€™s office in Manhattan are investigating transactions by hedge funds in both sectors, in connection with approvals of new medicines and acquisitions or mergers of businesses. On Monday, the FBI identified 300 people concerned in the investigation.